Enabling flexibility and scientific innovation in oral solid dose development
Enabling flexibility and scientific innovation in oral solid dose development
A strategic CDMO partnership enabled a clinical-stage pharmaceutical company to navigate the complexities of early drug development, advancing formulation strategies, adapting to shifting priorities, and ensuring a scalable path to clinical trials.

Added Date:

2025-05-14

Filters:

Filter Category Filter Values
Specialty
  • Other
Month
  • May
Capability
  • Oral Solid Dose
Year
  • 2025
Language
  • Korean
Asset Type
  • Blog
Country
  • Korea
Region
  • Asia Pacific (APAC)
Content Category
  • Collateral
Market Category
  • Small molecule

Country Availability:


()

Gated Form:

None Set